With the analysis among 572 patents, we discovered top 186 key players by total patent application. F. Hoffmann-La Roche Ltd., Atriva Therapeutics GmbH, Savira Pharmaceuticals are dominant in this area. They take 21.15% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Baden-Württemberg, Germany
Patent: 24
3M Innovative Properties Co.
Minnesota, United States
Patent: 20
Basel-Stadt, Switzerland
Patent: 13
California, United States
Patent: 11
The Board of Regents of The University of Texas System
Texas, United States
Patent: 9
Texas, United States
Patent: 8
Tarsus Pharmaceuticals, Inc.
California, United States
Patent: 8
Shandong Dyne Marine Biopharmaceutical Co., Ltd
With the analysis among 41 patents, we discovered top 7 start-ups by total patent application. Atriva Therapeutics GmbH, Institut National de la Santé et de la Recherche Médicale, Aventis, Inc. are active in this area.
Baden-Württemberg, Germany
Patent: 24
Institut National de la Santé et de la Recherche Médicale
New Jersey, United States
Patent: 2
Marigen Institute of Learning, Inc.
California, United States
Patent: 2
Stingray Therapeutics, Inc.
Texas, United States
Patent: 2
Prilenia Therapeutics Development Ltd.
Basel-Stadt, Switzerland
Patent: 1
With the analysis among related 422 patents applied in the last 5 years. We discover 132 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Atriva Therapeutics GmbH, Medikine, Inc. take 17.30% of patent filing during this period.
F. Hoffmann-La Roche Ltd.
Baden-Württemberg, Germany
Patent: 20
California, United States
Patent: 11
The Board of Regents of The University of Texas System
Texas, United States
Patent: 9
Texas, United States
Patent: 8
Shandong Dyne Marine Biopharmaceutical Co., Ltd
Tarsus Pharmaceuticals, Inc.
California, United States
Patent: 8
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 8
Basel-Stadt, Switzerland
Patent: 7
With the analysis among related 422 patents in last 5 years, we discover 113 new entrants. Medikine, Inc., The Board of Regents of The University of Texas System, Moleculin Biotech, Inc. are the most active new entrants in this area.
California, United States
Patent: 11
The Board of Regents of The University of Texas System
Texas, United States
Patent: 9
Texas, United States
Patent: 8
Shandong Dyne Marine Biopharmaceutical Co., Ltd
Tarsus Pharmaceuticals, Inc.
California, United States
Patent: 8
Basel-Stadt, Switzerland
Patent: 7
Shandong Buchang Pharmaceuticals Co., Ltd.
Shandong Sheng, China
Patent: 5
Jounce Therapeutics, Inc.
Massachusetts, United States
Patent: 5
Institute of Organic Chemistry & Biochemistry AS CR v.v.i
With the analysis among 141 patents, we discovered top 35 universities and scientific research institutions by total patent application. The European Molecular Biology Laboratory, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Katholieke Universiteit Leuven are dominant in this area. They take 41.13% of the total patent filing.
The European Molecular Biology Laboratory
Baden-Württemberg, Germany
Patent: 20
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 9
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 6
University of Connecticut
Connecticut, United States
Patent: 4
Macau University of Science & Technology
Macao SAR, China
Patent: 3
The Johns Hopkins University
The Rockefeller University
New York, United States
Patent: 2
Oost-Vlaanderen, Belgium
Patent: 2
Vrije Universiteit Brussel
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 2
École Polytechnique Fédérale de Lausanne
Vaud, Switzerland
Patent: 2